Levomed (Carbidopa, Levodopa)

Levodopa is a precursor that crosses the blood‑brain barrier and is converted into dopamine, addressing the deficiency seen in Parkinsonian disorders. Carbidopa blocks the peripheral enzyme that would otherwise convert levodopa outside the brain, allowing more levodopa to reach the central nervous system.

The appropriate dose of Levomed is individualized and determined by the prescribing clinician based on the patient’s condition, response, and tolerability. Dosage adjustments are made during treatment to achieve optimal symptom control while minimizing side effects.

The safety of Levomed in pregnancy and lactation has not been established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To request Levomed, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levomed combines carbidopa with levodopa, offering a balanced approach that maximizes central dopamine production while reducing peripheral side effects. Compared with dopamine agonists, it generally provides stronger symptom relief but may have a higher incidence of motor complications such as dyskinesia.

Levomed tablets should be stored at ambient temperature, below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and do not use after the expiry date.

Levomed is taken orally, usually with a glass of water. It can be taken with or without food, but high‑protein meals may interfere with levodopa absorption, so spacing the dose from large protein‑rich meals is often recommended.

Serious risks include severe psychiatric reactions such as hallucinations, profound hypotension, cardiac arrhythmias, and rare but life‑threatening conditions like neuroleptic malignant syndrome or severe allergic reactions. Patients should be monitored closely for these events.

Levomed is contraindicated in patients with known hypersensitivity to carbidopa, levodopa, or any excipients, and in those taking non‑selective MAO inhibitors. Caution is advised for individuals with severe cardiovascular disease, uncontrolled hypertension, or a history of psychosis.